{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:10:39Z","timestamp":1792300239160,"version":"4.4.0"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1097\/01.mcg.0000225570.04773.5d","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T09:39:22Z","timestamp":1159781962000},"page":"833-841","source":"Crossref","is-referenced-by-count":58,"title":["Acute Alcoholic Hepatitis"],"prefix":"10.1097","volume":"40","author":[{"given":"Mauro","family":"Ceccanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Attili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Attilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido Francesco","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Xirouchakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Attilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/00365529009093136","article-title":"Alcoholic hepatitis: pathogenesis and approaches to treatment","volume":"25 (suppl)","author":"Maddrey","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"R3-13-20210305","first-page":"1885","article-title":"Harrison's Principles of Internal Medicine","author":"Mailliard","year":"2001"},{"key":"R4-13-20210305","first-page":"1199","article-title":"Sleisenger and Fordtran's Gastrointestinal and Liver Disease","author":"Maher","year":"1998"},{"key":"R5-13-20210305","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hepres.2004.08.016","article-title":"Recent understanding of immunological aspects in alcoholic hepatitis","volume":"30","author":"Saito","year":"2004","journal-title":"Hepatol Res"},{"key":"R6-13-20210305","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI115141","article-title":"Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption","volume":"87","author":"Niemela","year":"1991","journal-title":"J Clin Invest"},{"key":"R7-13-20210305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0016-5085(97)70104-5","article-title":"Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol","volume":"113","author":"Clot","year":"1997","journal-title":"Gastroenterol"},{"key":"R8-13-20210305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5849(02)01167-X","article-title":"Oxidative stress in viral and alcoholic hepatitis","volume":"34","author":"Loguercio","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"R9-13-20210305","first-page":"210","article-title":"Prognostic factors in alcoholic liver disease. VA Cooperative Study Group","volume":"86","author":"Chedid","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"R10-13-20210305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0741-8329(02)00211-2","article-title":"Cellular and molecular mechanisms of alcoholic hepatitis: introduction and summary of the symposium","volume":"27","author":"Purohit","year":"2002","journal-title":"Alcohol"},{"key":"R12-13-20210305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11938-001-0016-4","article-title":"Alcoholic hepatitis","volume":"4","author":"Bui Han","year":"2001","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"4","key":"R13-13-20210305","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1111\/j.1530-0277.1999.tb04531.x","article-title":"Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group","volume":"23","author":"Fujimoto","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"R14-13-20210305","first-page":"335","article-title":"The prognosis and outcome of alcoholic liver disease","volume":"2","author":"Morgan","year":"1994","journal-title":"Alcohol Alcohol Suppl"},{"key":"R15-13-20210305","first-page":"108","article-title":"Severe acute alcoholic hepatitis: an audit of medical treatment","volume":"95","author":"O'Keefee","year":"2002","journal-title":"Ir Med J"},{"key":"R16-13-20210305","first-page":"48","article-title":"Treatment of alcoholic hepatitis","volume":"17","author":"Maher","year":"2002","journal-title":"Gastroenterol Hepatol"},{"key":"R17-13-20210305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0168-8278(96)80156-5","article-title":"Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival","volume":"24","author":"Huang","year":"1996","journal-title":"J Hepatol"},{"key":"R18-13-20210305","first-page":"161","article-title":"International Encyclopedia of Pharmacology and Therapeutics","volume":"1","author":"Wallgren","year":"1970"},{"key":"R19-13-20210305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(96)06434-0","article-title":"Ethanol metabolism, cirrhosis and alcoholism","volume":"257","author":"Lieber","year":"1997","journal-title":"Clin Chim Acta"},{"key":"R20-13-20210305","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM198812223192505","article-title":"Biochemical and molecular basis of alcohol-induced injury to liver and other tissues","volume":"319","author":"Lieber","year":"1988","journal-title":"NEJM"},{"key":"R21-13-20210305","first-page":"7","article-title":"Ethanol suppresses hepatic glutathione synthesis in rats in vivo","volume":"230","author":"Lautenburg","year":"1984","journal-title":"J Pharm Exp Ther"},{"key":"R22-13-20210305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.1840070607","article-title":"Antibodies against qacetaldheide-modified protein hepitopes in human alcoholics","volume":"7","author":"Niemela","year":"1987","journal-title":"Hepatology"},{"key":"R23-13-20210305","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jama.1986.03380110077030","article-title":"liver fibrosis in alcoholics: detection of Fab radioimmunassay of serum procollagen III peptides","volume":"256","author":"Sato","year":"1986","journal-title":"JAMA"},{"key":"R24-13-20210305","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","article-title":"Cytochrome P-4502E1: its physiological and pathological role","volume":"77","author":"Lieber","year":"1997","journal-title":"Physiol Rev"},{"key":"R25-13-20210305","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/gut.28.9.1157","article-title":"Free radical generation by neutrophils: a potential mechanism of cellular injury in acute alcoholic hepatitis","volume":"28","author":"Williams","year":"1987","journal-title":"Gut"},{"key":"R26-13-20210305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","article-title":"Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay","volume":"12","author":"Fukui","year":"1991","journal-title":"J Hepatol"},{"key":"R27-13-20210305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.1840200227","article-title":"Inactivation of Kupffer cells prevents early alcohol-induced liver injury","volume":"20","author":"Adachi","year":"1994","journal-title":"Hepatology"},{"key":"R28-13-20210305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"key":"R29-13-20210305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(88)90006-2","article-title":"Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure","volume":"2","author":"Muto","year":"1988","journal-title":"Lancet"},{"key":"R30-13-20210305","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1074\/jbc.275.4.2410","article-title":"Characterization of IRAK in normal and endotoxin tolerant cells","volume":"275","author":"Li","year":"2000","journal-title":"J Biol Chem"},{"key":"R31-13-20210305","first-page":"300","article-title":"Endotoxin and Kupffer cell activation in alcoholic liver disease","volume":"27","author":"Wheeler","year":"2003","journal-title":"Alcohol Research & Health (Bethesda)"},{"key":"R32-13-20210305","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2000.19621","article-title":"Exacerbation of alcoholic liver injury by enteral endotoxin in rats","volume":"32","author":"Mathurin","year":"2000","journal-title":"Hepatology"},{"key":"R33-13-20210305","first-page":"321","article-title":"Oxidative stress and alcoholic liver disease","volume":"21","author":"Fernandez-Checa","year":"1997","journal-title":"Alcohol Health Res World"},{"key":"R34-13-20210305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1582-4934.2004.tb00469.x","article-title":"Dissection of the multiple mechanisms of TNF-\u03b1-induced apoptosis in liver injury","volume":"8","author":"Ding","year":"2004","journal-title":"J Cell Mol Med"},{"key":"R35-13-20210305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0891-5849(01)00769-9","article-title":"Contribution of mitochondria to oxidative stress associated with alcoholic liver disease","volume":"32","author":"Bailey","year":"2002","journal-title":"Free Radical Biol Med"},{"key":"R36-13-20210305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0741-8329(02)00215-X","article-title":"Ethanol, oxidative stress, and cytokine-induced liver cell injury","volume":"27","author":"Hoek","year":"2002","journal-title":"Alcohol"},{"key":"R37-13-20210305","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1566524033479555","article-title":"Death receptor activation-induced hepatocyte apoptosis and liver injury","volume":"3","author":"Yin","year":"2003","journal-title":"Curr Mol Med"},{"key":"R38-13-20210305","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1053\/gast.2002.33613","article-title":"Alcohol and mitochondria: a dysfunctional relationship","volume":"122","author":"Hoek","year":"2002","journal-title":"Gastroenterol"},{"issue":"4","key":"R39-13-20210305","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R40-13-20210305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0399-8320(05)80760-2","article-title":"Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis","volume":"29","author":"Naveau","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"R41-13-20210305","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1111\/j.1530-0277.2000.tb00016.x","article-title":"Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis","volume":"24","author":"Takahashi","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R42-13-20210305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0741-8329(02)00200-8","article-title":"Neutrophil-mediated tissue injury in alcoholic hepatitis","volume":"27","author":"Jaeschke","year":"2002","journal-title":"Alcohol"},{"key":"R43-13-20210305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1023\/A:1014783815433","article-title":"IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease?","volume":"47","author":"Parlesak","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R44-13-20210305","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0168-8278(01)00190-8","article-title":"Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood","volume":"35","author":"Spahr","year":"2001","journal-title":"J Hepatol"},{"key":"R45-13-20210305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"R46-13-20210305","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0168-8278(98)80227-4","article-title":"Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity","volume":"28","author":"Naveau","year":"1998","journal-title":"J Hepatol"},{"key":"R47-13-20210305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0168-8278(00)00089-1","article-title":"Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis","volume":"34","author":"Natori","year":"2001","journal-title":"J Hepatol"},{"key":"R48-13-20210305","first-page":"443","article-title":"Fas-mediated apoptosis in acute alcoholic hepatitis","volume":"50","author":"Tagami","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R49-13-20210305","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"R50-13-20210305","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","article-title":"Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"},{"key":"R51-13-20210305","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510260621","article-title":"Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat","volume":"26","author":"Iimuro","year":"1997","journal-title":"Hepatology"},{"key":"R52-13-20210305","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02934504","article-title":"Molecular mechanisms of hepatic fibrosis and principles of therapy","volume":"32","author":"Friedman","year":"1997","journal-title":"J Gastroenterol"},{"key":"R53-13-20210305","article-title":"Marker Biologici Dell'abuso Alcolico","author":"Sasso","year":"2004"},{"key":"R54-13-20210305","first-page":"451","article-title":"A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum","volume":"1","author":"Stibler","year":"1991","journal-title":"Alcohol Alcoholism"},{"issue":"9","key":"R55-13-20210305","doi-asserted-by":"crossref","first-page":"383A","DOI":"10.1111\/j.1530-0277.1996.tb01813.x","article-title":"Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression","volume":"20","author":"Kumashiro","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"R56-13-20210305","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R57-13-20210305","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"Cardenas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R58-13-20210305","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00004836-200205000-00019","article-title":"Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis","volume":"34","author":"Han","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R59-13-20210305","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"R60-13-20210305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R61-13-20210305","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Metilprednisolone therapy in patients with severe alcoholic hepatitis","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"R62-13-20210305","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"R63-13-20210305","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"R64-13-20210305","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/gut.2004.063420","article-title":"Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?","volume":"54","author":"Tilgh","year":"2005","journal-title":"Gut"},{"key":"R65-13-20210305","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factor predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"R66-13-20210305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(86)80006-X","article-title":"Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage","volume":"2","author":"Pares","year":"1986","journal-title":"J Hepatol"},{"key":"R67-13-20210305","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Meta-analysis of propylthiouracil for alcoholic liver disease\u2014a Cochrane Hepato-Biliary Group review","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"key":"R68-13-20210305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"R69-13-20210305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"key":"R70-13-20210305","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"key":"R71-13-20210305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.1840110203","article-title":"S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon","volume":"11","author":"Lieber","year":"1990","journal-title":"Hepatology"},{"key":"R72-13-20210305","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"R73-13-20210305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0741-8329(02)00230-6","article-title":"S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings","volume":"27","author":"Lieber","year":"2002","journal-title":"Alcohol"},{"key":"R74-13-20210305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0891-5849(92)90030-K","article-title":"Implication of free radical mechanisms in ethanol-induced cellular injury","volume":"12","author":"Nordmann","year":"1992","journal-title":"Free Radic Biol Med"},{"key":"R75-13-20210305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.ALC.0000108654.77178.03","article-title":"Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis","volume":"28","author":"Lee","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R76-13-20210305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"R77-13-20210305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"R78-13-20210305","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1440-1746.2002.02722.x","article-title":"Treatment of alcoholic hepatitis","volume":"17","author":"Maher","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R79-13-20210305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R80-13-20210305","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"R81-13-20210305","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/hep.20475","article-title":"Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis","volume":"40","author":"Duvoux","year":"2004","journal-title":"Hepatology"},{"key":"R82-13-20210305","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/00042737-200412000-00023","article-title":"Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study","volume":"16","author":"Alvarez","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R83-13-20210305","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","article-title":"Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline","volume":"155","author":"Strieter","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R84-13-20210305","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1440-1746.2003.03217.x","article-title":"Pathogenesis and management of alcoholic hepatitis","volume":"18","author":"Haber","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R85-13-20210305","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"R86-13-20210305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.01.032","article-title":"Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis","volume":"43","author":"Sen","year":"2005","journal-title":"J Hepatol"},{"key":"R87-13-20210305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"issue":"8","key":"R88-13-20210305","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/01.ALC.0000078607.32247.9D","article-title":"Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report","volume":"27","author":"Tsuji","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R89-13-20210305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"R90-13-20210305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502250","article-title":"Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis-factor-alpha-neutralizing antibody: a possible healthcare-associated case?","volume":"2","author":"De Rosa","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R91-13-20210305","first-page":"111","article-title":"TNF-alpha blockade and tuberculosis: better look before you leap","volume":"61","author":"Arend","year":"2003","journal-title":"Neth J Med"},{"key":"R93-13-20210305","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"R94-13-20210305","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"R95-13-20210305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R96-13-20210305","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1053\/gast.2001.23253","article-title":"Delivery of the Cu\/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats","volume":"120","author":"Wheeler","year":"2001","journal-title":"Gastroenterology"},{"key":"R97-13-20210305","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/jhep.2001.29400","article-title":"Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats","volume":"34","author":"Uesugi","year":"2001","journal-title":"Hepatology"},{"key":"R98-13-20210305","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2036.2000.00740.x","article-title":"Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients","volume":"14","author":"Dagher","year":"2000","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200610000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:01:43Z","timestamp":1618030903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200610000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mcg.0000225570.04773.5d","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}